- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02806297
Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis
March 25, 2021 updated by: Lillian Kao, The University of Texas Health Science Center, Houston
A Randomized Trial of the Effect of Timing of Cholecystectomy During Initial Admission for Mild Gallstone Pancreatitis
Randomized trial of laparoscopic cholecystectomy with cholangiogram on admission versus after resolution of pain for mild gallstone pancreatitis.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The purpose of this study is to perform a single-center randomized trial to compare laparoscopic cholecystectomy with intraoperative cholangiogram (IOC) within 24 hours of presentation versus after clinical resolution during index admission for mild gallstone pancreatitis on clinical and patient-reported outcomes.
Additionally, this study aims to determine patients' values and preferences that influence decision-making regarding treatment options for gallstone pancreatitis.
Hypothesis: During index admission for mild gallstone pancreatitis, early cholecystectomy within 24 hours of presentation regardless of symptoms or laboratory values versus after clinical resolution results in a shorter 30-day total hospital length of stay.
Study Type
Interventional
Enrollment (Actual)
100
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Houston, Texas, United States, 77026
- Lyndon B. Johnson General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
Diagnosis of gallstone pancreatitis. Patients will be considered to have gallstone pancreatitis if they have:
- upper abdominal pain, nausea, vomiting, and epigastric tenderness
- absence of ethanol abuse
- elevated lipase level above the upper limit of normal (>370 U/L)
- imaging confirmation of gallstones or sludge
- Low predicted mortality using the Bedside Index of Severity in Acute Pancreatitis (BISAP) -Diagnosis of mild pancreatitis (i.e.,no evidence of organ failure or local or systemic complications)
- Scheduled for laparoscopic cholecystectomy prior to discharge
- Lack of any very strong indicator for choledocholithiasis based on the American Society for Gastrointestinal Endoscopy (ASGE) guidelines
- Clinical stability as denoted by admission to a non-monitored floor bed.
Exclusion criteria
- Pregnancy
- Severe preexisting medical comorbidities precluding surgery, organ failure, local or systemic complications of acute pancreatitis
- Chronic pancreatitis
- Native language other than English and Spanish
- Patient refusal to participate
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Early cholecystectomy with IOC
The experimental arm will be laparoscopic cholecystectomy with intraoperative cholangiogram (IOC) on admission within 24 hours of presentation regardless of whether pain or tenderness are present or laboratory values are elevated.
|
The intervention will be laparoscopic cholecystectomy with intraoperative cholangiogram (IOC) on admission within 24 hours of presentation regardless of whether pain or tenderness are present or laboratory values are elevated.
|
Active Comparator: Late cholecystectomy with IOC
The comparator will be laparoscopic cholecystectomy with IOC once the patient has met the following criteria: (a) a score of less than 2 on the Visual Analogue Pain Scale, (b) no tenderness on physical exam, and (c) decreased lipase to either less than half of the peak value or within normal range (73-393 U/L).
|
The control will be laparoscopic cholecystectomy with IOC once the patient has met the following criteria: (a) a score of less than 2 on the Visual Analogue Pain Scale, (b) no tenderness on physical exam, and (c) decreased lipase to either less than half of the peak value or within normal range (73-393 U/L).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
30-day hospital length of stay
Time Frame: 30 days
|
30 days
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Time from admission to cholecystectomy
Time Frame: up to 10 days
|
up to 10 days
|
Initial hospital LOS
Time Frame: up to 30 days
|
up to 30 days
|
Number of participants who underwent conversion to open cholecystectomy
Time Frame: 30 days
|
30 days
|
Change in patient reported outcomes as assessed by the Gastrointestinal Quality-of-Life Index (GIQLI)
Time Frame: baseline, 1 week
|
baseline, 1 week
|
Change in patient reported outcomes as assessed by the Gastrointestinal Quality-of-Life Index (GIQLI) and Patients' Experience of Surgery Questionnaire (PESQ)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change in patient reported outcomes as assessed by the Patients' Experience of Surgery Questionnaire (PESQ)
Time Frame: baseline, 1 week
|
baseline, 1 week
|
Change in patient reported outcomes as assessed by the Patients' Experience of Surgery Questionnaire (PESQ)
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Change in health-related quality of life as assessed by the standard gamble
Time Frame: baseline, 1 week
|
baseline, 1 week
|
Change in health-related quality of life as assessed by the standard gamble
Time Frame: baseline, 6 weeks
|
baseline, 6 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Lillian S Kao, MD, The University of Texas Health Science Center, Houston
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Mueck KM, Wei S, Pedroza C, Bernardi K, Jackson ML, Liang MK, Ko TC, Tyson JE, Kao LS. Gallstone Pancreatitis: Admission Versus Normal Cholecystectomy-a Randomized Trial (Gallstone PANC Trial). Ann Surg. 2019 Sep;270(3):519-527. doi: 10.1097/SLA.0000000000003424.
- Mueck KM, Wei S, Liang MK, Ko TC, Tyson JE, Kao LS. Protocol for a randomized trial of the effect of timing of cholecystectomy during initial admission for predicted mild gallstone pancreatitis at a safety-net hospital. Trauma Surg Acute Care Open. 2018 Jan 20;3(1):e000152. doi: 10.1136/tsaco-2017-000152. eCollection 2018.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 1, 2016
Primary Completion (Actual)
June 28, 2018
Study Completion (Actual)
August 11, 2018
Study Registration Dates
First Submitted
June 13, 2016
First Submitted That Met QC Criteria
June 15, 2016
First Posted (Estimate)
June 20, 2016
Study Record Updates
Last Update Posted (Actual)
March 30, 2021
Last Update Submitted That Met QC Criteria
March 25, 2021
Last Verified
March 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HSC-MS-15-0719
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pancreatitis
-
Changhai HospitalUnknownChronic Pancreatitis | Idiopathic Chronic PancreatitisChina
-
Centre Hospitalier Universitaire de NiceRecruiting
-
Copenhagen University Hospital, HvidovreRecruitingFibrosis | Inflammation | Pancreatitis | Chronic Pancreatitis | Acute Pancreatitis | Recurrent PancreatitisDenmark
-
Tianjin Nankai HospitalCompletedAcute PancreatitisChina
-
Massachusetts General HospitalTerminatedChronic Pancreatitis | Acute Recurrent PancreatitisUnited States
-
Changhai HospitalEnrolling by invitationChronic Pancreatitis | Acute Pancreatitis | Healthy PeopleChina
-
Postgraduate Institute of Medical Education and...Completed
-
Dartmouth-Hitchcock Medical CenterCompleted
-
The Cleveland ClinicChiRhoClin, Inc.; The National Pancreas FoundationCompletedChronic PancreatitisUnited States
Clinical Trials on Early cholecystectomy with IOC
-
South Valley UniversitySohag UniversityCompletedAcute Biliary Pancreatitis
-
Sohag UniversityRecruitingCholelithiasesEgypt
-
Hospital del SalvadorTerminatedGallstone PancreatitisChile
-
IRCCS Policlinico S. MatteoCompleted
-
Damanhour Teaching HospitalCompletedAcute CholecystitisEgypt
-
Fundación de Investigación Biomédica - Hospital...Marcello Di MartinoCompleted
-
University Hospital, Basel, SwitzerlandClinical Trial Unit, University Hospital Basel, SwitzerlandCompleted
-
Mansoura UniversityUnknownAcute Cholecystitis: Early Versus Delayed Laparoscopic Cholecystectomy; Randomized Prospective StudyAcute CholecystitisEgypt
-
Mansoura UniversityCompletedGallbladder and Bile Duct Calculi
-
University Hospital, GenevaCompletedCholecystitis | Cholangitis | Choledocholithiasis | Gallstone Pancreatitis | Gallstone MigrationSwitzerland